Prior Auth Required

26026 - For updated guidelines, visit: https://www.guidelinecentral.com/guideline/ /#section-336178

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceFor updated guidelines, visit: https://www.guidelinecentral.com/guideline/ /#section-336178
Procedure / Service Description

Standard of care, rare indication, for rare diseases where demonstrated effectiveness exists but large - preclinical or early-phase clinical studies show promising results, and (5) not generally recommended, where available evidence does not support the routine use of hematopoietic stem cell transplantation. For updated guidelines, visit: https://www.guidelinecentral.com/guideline/26026/#section-336178 [accessed 2026 Jan 19]. Following the ASTCT guideline recommendations, several indication specific guidelines have been

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.